[药物研究和开发以及对晚期肝细胞癌的未满足需求]
1Department of Hepatobiliary Internal Medicine, Shanghai Eastern Hepatobiliary Surgery Hospital, Shanghai 200438, China.
概括
肝细胞癌 (HCC) 是一个重大的全球健康挑战. 虽然新的向疗法和免疫疗法提供了希望,但它们对治疗肝癌的整体有效性需要进一步提高.
科学领域:
- 在瘤学瘤学.
- 肝病学 肝病学是一种肝病学.
- 癌症研究 癌症研究
更多相关视频
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
8.9K
09:11Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
413
